Skip to main content

Asparaginase Erwinia chrysanthemi

Details of the Drug
Generic Name:
Asparaginase <em>Erwinia chrysanthemi</em>
Pronunciation:
as-PAYR-uh-jih-NAYS er-WIH-nee-uh krih-SAN-theh-my
Drug Type:
Enzyme that prevents cancer cells from surviving
How the Drug is Given:

Intramuscular (IM) injection

Names:
Erwinaze®
Asparaginase Erwinia chrysanthemi

Indications and Usage

Asparaginase Erwinia chrysanthemi is an asparagine specific enzyme indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (ALL) who have developed hypersensitivity to E. coli-derived asparaginase.

Side effects needing medical attention

Serious allergic reactions (tightness in throat, abnormal swelling/redness or difficulty breathing), some of which may be life-threatening; inflammation of the pancreatitis (stomach pain); abnormal blood clotting (may have headache, pain in leg, arm, or chest); unusual bleeding; liver problems; nausea, vomiting, and abnormal blood sugar levels (may be thirsty or frequently urinate).    

For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.